期刊文献+

STAT1过表达慢病毒载体的构建及其在MHCC97L细胞中的表达 被引量:4

Construction of STAT1 gene over-expression lentivirus vec- tor and expression in MHCC97L cells
下载PDF
导出
摘要 目的:构建STAT1基因过表达慢病毒载体并实现其在人肝癌细胞MHCC97L中的表达。方法:根据人STAT1基因mRNA序列,全基因合成STAT1基因,构建至过表达载体并转化至感受态细胞DH5α,进行测序验证。在脂质体介导下转染293T细胞,包装生产慢病毒。慢病毒载体转染人肝癌细胞MHCC97L,用荧光定量PCR和Western blot检测原始细胞株(MHCC97L),稳转细胞株(MHCC97-stat1)中STAT1的表达情况,确定STAT1过表达的有效性。结果:测序证实STAT1基因过表达载体构建成功。过表达慢病毒包装成功。慢病毒转染人肝癌细胞MHCC97L 48 h后,STAT1基因在mRNA水平和蛋白质水平上表达显著增加。结论:STAT1基因过表达慢病毒载体构建成功,并实现其在人肝癌细胞MHCC97L中的表达。 Objective: To construct lentiviral vectors of STAT1 gene overexpression and achieve their expression in MHCC97L of human hepatoma cells. Methods: Based on the mRNA sequence of human STAT1 gene, we made the total synthesis of STAT1 gene, to construct overexpression vectors and transformed them into competent cells DH5 a which we verified by sequencing. Under the liposome mediation 293T cells were transfected to achieve the lentivirus packaging production. Then MHCC97L of human hepatoma cells were transfected by tentiviral vectors. The ex- pression of STAT1 gene in both original cell lines (MHCC97L)and stable transfected cell lines (MHCC97-stat1)were detected by fluorescence quantitative PCR and Western blot in order to determine the validity of STAT1 gene overexpression. Results: It is confirmed that the overexpression vectors of STAT1 gene were constructed successfully by sequencing. The packaging of overex- pressing lentivirus was successfu1.48h after the lentivirus transfected MHCC97L of human hepatoma cells, the expression of STAT1 gene increased significantly at both the mRNAlevel and protein level. Conclusion: The lentiviral vectors of STAT1 gene overexpression were constructed successfully and we achieved their expression in MHCC97L of human hepatoma cells.
出处 《中国现代普通外科进展》 CAS 2013年第12期931-934,共4页 Chinese Journal of Current Advances in General Surgery
基金 国家自然科学基金(81001524) 北京中医药大学自主选题项目(2011JYBZZJS-020)
关键词 肝肿瘤 MHCC97L细胞 STAT1基因 慢病毒载体 Liver neoplasms M HCC97 L cells STAT1 gene. Lentivirus vector
  • 相关文献

参考文献5

  • 1周钧,钟德玝,杨竹林,胡继雄,邓星辉.STAT_1、STAT_2、STAT_4在原发性肝癌中的表达及意义[J].中华肝胆外科杂志,2004,10(12):838-840. 被引量:5
  • 2Heilbronn R, Weger S. Viral vectors for gene transfer: current status of gene therapeutics[J]. Handb Exp Pharmacol, 2010 ( 197 ):143-170.
  • 3Leite LH, Sharma NM, Bafna S, et al. Construction and validation otYlentiviral?vector?carrying rat neuronal nitrie oxide synthase in vitro and in vivo[J]. J Neurosci Melhods, 2012,211 ( 1):77-83.
  • 4Liu X, Tang Z, Zhang Y, et al. I,entivirall,7 overexpressed T-het regulates T-helper cell lineage commitment in chronic hepatitis B patients[J], Mol Med Report, 2012,6(2):361-366.
  • 5Chang SH, Chung YS, Hwang SK. Lentiviral veetor-mediated shRNA against AIMP2-DX2 suppresses lung cancer cell growth thrnugh hloeking glucose uptake[J]. Mol Cells, 2012,33 (6):553- 562.

二级参考文献1

共引文献4

同被引文献27

  • 1占国清,李儒贵,谭华炳,李芳,李刚,张薇薇.参芪扶正注射液对中晚期肝癌肝动脉化疗栓塞术后患者生存质量的影响[J].湖北医药学院学报,2013,32(4):325-328. 被引量:9
  • 2Chen G, Wang H, Xie S, et al. STAT1 negtitivelv regulates hepato-cellular can'ijioma cell proliferaliou [J], Oncol Kep, 2013, 29 (6):2303-2310.
  • 3Pushjmraj P!N, Aarthi JJ. Manikandan J, et al. siHNA, miKNA, andshli\A: in vivo applications [J]. J l)<*nt lies, 2008,87 (11 ):992-1003.
  • 4Parr-Hn?wnlie I义:,Bosrh-Bouju C, Sclioderljoet k L et al. Lentiviralv(*ctors as tools to understand central nervous system l)iologv innuimmulian niodt*! organisms[J]. h’mut Mol Neurosci. 2015,8:14.
  • 5Chatterjee S. De A. Applications of lentiviral vectors in molecularimaging[J]. Kront Biosci ([>an(lmark Kd), 2014.19:835-853.
  • 6Chen G1, Wang H, Xie S, et al. STAT1 negatively regulates hepato- cellular carcinoma cell proliferation[J]. Oneol Rep, 2013.29(6):2303- 2310.
  • 7Dyawanapelly S, Ghodke SB, Vishwanathan R, et al. RNA interfer- ence-based therapeutics: molecular platforms for infectious diseases[J]. J Biomed Nanotechnol, 2014, 10(9):1998-2037.
  • 8Battistella M, Marsden PA. Advances, nuances, and potential pit- falls when exploiting the therapeutic potential of RNA interference[J].Clin Pharmacol Ther, 2015 97(1):79-87.
  • 9Du P, Zhang X, Liu H, et al. Lentivirus-Mediated RNAi Silencing Targeting ERCCI Reverses Cisplatin Resistance in Cisplatin-Re- sistant Ovarian Carcinoma Cell Line[l]. DNA Cell Biol, 2015,34(7): 497-502.
  • 10Fan G, Bo J, Wan R, et al. The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor Is on the up- take of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988[J]. Cancer Biothcr Radiopharm, 2015,30(4):160- 168.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部